Localization of the Apoptosis-inducing Activity of Lupus Anticoagulant in an Annexin V-binding Antibody Subset

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1998 Jun 13

PMID 9576760

Citations 4

Authors

N Nakamura

T Ban

K Yamaji

Y Yoneda

Y Wada

Affiliations

Soon will be listed here.

Abstract

Lupus anticoagulant (LAC) is associated with arterial and venous thrombosis, thrombocytopenia, and recurrent fetal loss. We have reported previously that plasma with LAC activity induces apoptosis in endothelial cells and binds annexin V (Nakamura, N., Y. Shidara, N. Kawaguchi, C. Azuma, N. Mitsuda, S. Onishi, K. Yamaji, and Y. Wada. 1994. Biochem. Biophys. Res. Commun. 205:1488-1493). In this study, we separated two IgG antibody fractions, one with and one without affinity for annexin V, from 10 patients with LAC. LAC and apoptotic activities were localized in the annexin V-binding fraction in all 10 patients. DNA fragmentation was dose-dependent, paralleling the amount of IgG added to the human umbilical vein endothelial cell culture medium, and was inhibited by preincubation with annexin V. Removal of the antiphospholipid antibodies from patient IgG with phospholipid liposomes did not abolish the apoptosis-inducing activities or binding to annexin V. These results imply that patients with LAC often have antibodies that do not bind phospholipids and are responsible for the induction of apoptosis in endothelial cells.

Citing Articles

Autoantibodies and coagulation in reproductive medicine.

Matsubayashi H Reprod Med Biol. 2018; 8(4):131-140.

PMID: 29662422 PMC: 5891802. DOI: 10.1007/s12522-009-0026-9.

Autoimmune mechanisms in children with systemic lupus erythematosus.

Stichweh D, Pascual V Curr Rheumatol Rep. 2005; 7(6):421-6.

PMID: 16303100 DOI: 10.1007/s11926-005-0045-4.

Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity.

Tripathy N, Sinha N, Nityanand S Clin Exp Immunol. 2003; 134(2):360-4.

PMID: 14616799 PMC: 1808857. DOI: 10.1046/j.1365-2249.2003.02282.x.

[Apoptosis--what is it? Significance in coronary heart disease and myocardial infarct].

Holtz J, Heinrich H Herz. 1999; 24(3):196-210.

PMID: 10412643 DOI: 10.1007/BF03044962.

References

Creutz C . The annexins and exocytosis. Science. 1992; 258(5084):924-31. DOI: 10.1126/science.1439804. View

Branch D, Rodgers G . Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol. 1993; 168(1 Pt 1):206-10. DOI: 10.1016/s0002-9378(12)90915-1. View

Triplett D . Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol. 1992; 28(3-4):211-5. DOI: 10.1111/j.1600-0897.1992.tb00794.x. View

Carreras L, Maclouf J . The lupus anticoagulant and eicosanoids. Prostaglandins Leukot Essent Fatty Acids. 1993; 49(1):483-8. DOI: 10.1016/0952-3278(93)90035-u. View

Matsuura E, Igarashi Y, Yasuda T, Triplett D, Koike T . Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 1994; 179(2):457-62. PMC: 2191370. DOI: 10.1084/jem.179.2.457. View

Martinuzzo M, Maclouf J, Carreras L, Levy-Toledano S . Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost. 1993; 70(4):667-71. View

Raynal P, Pollard H . Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1994; 1197(1):63-93. DOI: 10.1016/0304-4157(94)90019-1. View

Santoro S . Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms. Blood. 1994; 83(9):2389-91. View

van Heerde W, Sakariassen K, Hemker H, Sixma J, Reutelingsperger C, de Groot P . Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler Thromb. 1994; 14(5):824-30. DOI: 10.1161/01.atv.14.5.824. View

10.

Nakamura N, Kuragaki C, Shidara Y, Yamaji K, Wada Y . Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties. Am J Hematol. 1995; 49(4):347-8. DOI: 10.1002/ajh.2830490414. View

11.

Rothhut B, Dubois T, Feliers D, Oudinet J . Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur J Biochem. 1995; 232(3):865-72. View

12.

Simantov R, Lasala J, Lo S, Gharavi A, Sammaritano L, Salmon J . Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest. 1995; 96(5):2211-9. PMC: 185871. DOI: 10.1172/JCI118276. View

13.

Bennett M, Gibson D, Schwartz S, Tait J . Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res. 1995; 77(6):1136-42. DOI: 10.1161/01.res.77.6.1136. View

14.

Rand J, Wu X, Andree H, Lockwood C, Guller S, Scher J . Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. N Engl J Med. 1997; 337(3):154-60. DOI: 10.1056/NEJM199707173370303. View

15.

Reutelingsperger C, van Heerde W . Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci. 1997; 53(6):527-32. PMC: 11147358. DOI: 10.1007/s000180050067. View

16.

Matsuda R, Kaneko N, Horikawa Y . Presence and comparison of Ca2+ transport activity of annexins I, II, V, and VI in large unilamellar vesicles. Biochem Biophys Res Commun. 1997; 237(3):499-503. DOI: 10.1006/bbrc.1997.7177. View

17.

Thiagarajan P, Benedict C . Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation. 1997; 96(7):2339-47. DOI: 10.1161/01.cir.96.7.2339. View

18.

Sanfelippo M, Drayna C . Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis. Am J Clin Pathol. 1982; 77(3):275-9. DOI: 10.1093/ajcp/77.3.275. View

19.

Carreras L, Vermylen J . "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation. Thromb Haemost. 1982; 48(1):38-40. View

20.

Tan E, Cohen A, Fries J, MASI A, McShane D, Rothfield N . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-7. DOI: 10.1002/art.1780251101. View